Reuters logo
5 months ago
BRIEF-Forward Pharma receives $1.25 bln pursuant to settlement and license agreement with Biogen
February 9, 2017 / 2:07 PM / 5 months ago

BRIEF-Forward Pharma receives $1.25 bln pursuant to settlement and license agreement with Biogen

1 Min Read

Feb 9 (Reuters) - Forward Pharma A/S -

* Forward Pharma received US$ 1.25 bln pursuant to settlement and license agreement with Biogen

* Forward Pharma A/S - received non-refundable cash fee of US$1.25 billion in connection with settlement and license agreement with two units of Biogen Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below